Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided?
作者信息
Hayashi Paul H, Chalasani Naga P
出版信息
CMAJ. 2012 Oct 2;184(14):1555-6. doi: 10.1503/cmaj.121270. Epub 2012 Aug 13.
Abstract
摘要
相似文献
1
Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided?
CMAJ. 2012 Oct 2;184(14):1555-6. doi: 10.1503/cmaj.121270. Epub 2012 Aug 13.
2
[Moxifloxacin and hepatic toxicity].
Gastroenterol Hepatol. 2009 Dec;32(10):719-20. doi: 10.1016/j.gastrohep.2009.06.004. Epub 2009 Aug 6.
3
Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study.
CMAJ. 2012 Oct 2;184(14):1565-70. doi: 10.1503/cmaj.111823. Epub 2012 Aug 13.
4
Recurrent episodes of hypoglycemia induced by moxifloxacin.
Indian J Pharmacol. 2013 May-Jun;45(3):301-2. doi: 10.4103/0253-7613.111908.
5
Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens.
Int J Tuberc Lung Dis. 2011 Sep;15(9):1275-6. doi: 10.5588/ijtld.11.0352.
6
Moxifloxacin-induced rhabdomyolysis.
Intensive Care Med. 2012 Apr;38(4):725. doi: 10.1007/s00134-012-2502-7. Epub 2012 Feb 10.
7
Prulifloxacin ECG study.
Clin Drug Investig. 2010;30(4):275-7. doi: 10.2165/11311700-000000000-00000.
8
Acute iris depigmentation following systemic moxifloxacin.
Clinics (Sao Paulo). 2013 Jul;68(7):899-900. doi: 10.6061/clinics/2013(07)02.
9
Moxifloxacin: new indication. Inadequate restriction of indications in ENT and respiratory infections.
Prescrire Int. 2009 Oct;18(103):206.
10
Drug Points: tachycardia associated with moxifloxacin.
BMJ. 2001 Jan 6;322(7277):23. doi: 10.1136/bmj.322.7277.23.
引用本文的文献
1
Comparative Analysis of Adverse Drug Reactions Associated with Fluoroquinolones and Other Antibiotics: A Retrospective Pharmacovigilance Study.
Drug Healthc Patient Saf. 2025 Feb 5;17:51-62. doi: 10.2147/DHPS.S497112. eCollection 2025.
2
Safety of Delafloxacin: Focus on Adverse Events of Special Interest.
Open Forum Infect Dis. 2018 Sep 10;5(10):ofy220. doi: 10.1093/ofid/ofy220. eCollection 2018 Oct.
本文引用的文献
1
Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study.
CMAJ. 2012 Oct 2;184(14):1565-70. doi: 10.1503/cmaj.111823. Epub 2012 Aug 13.
2
Management of bacterial infections in cirrhosis.
J Hepatol. 2012;56 Suppl 1:S1-12. doi: 10.1016/S0168-8278(12)60002-6.
3
Management of adult patients with ascites due to cirrhosis: an update.
Hepatology. 2009 Jun;49(6):2087-107. doi: 10.1002/hep.22853.
4
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes.
Drug Saf. 2009;32(5):359-78. doi: 10.2165/00002018-200932050-00001.
5
Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases.
Hepatology. 2009 Jan;49(1):250-7. doi: 10.1002/hep.22620.
6
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.
Gastroenterology. 2008 Dec;135(6):1924-34, 1934.e1-4. doi: 10.1053/j.gastro.2008.09.011. Epub 2008 Sep 17.
7
Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data.
BMC Health Serv Res. 2007 Oct 2;7:159. doi: 10.1186/1472-6963-7-159.
8
Hepatic adverse drug reactions: a case/non-case study in Italy.
Eur J Clin Pharmacol. 2007 Jan;63(1):73-9. doi: 10.1007/s00228-006-0222-z. Epub 2006 Nov 22.
9
Suspected drug-induced liver fatalities reported to the WHO database.
Dig Liver Dis. 2006 Jan;38(1):33-8. doi: 10.1016/j.dld.2005.06.004. Epub 2005 Jul 28.
Zotero 插件